Cargando…

A Phosphatase‐Mimetic Nano‐Stabilizer of Mast Cells for Long‐Term Prevention of Allergic Disease

Allergic diseases are pathological immune responses with significant morbidity, which are closely associated with allergic mediators as released by allergen‐stimulated mast cells (MCs). Prophylactic stabilization of MCs is regarded as a practical approach to prevent allergic diseases. However, most...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Peihua, Cao, Mengda, Xia, Fan, Liao, Hongwei, Sun, Heng, Wang, Qiyue, Lee, Jiyoung, Zhou, Yan, Guan, Yunan, Zhang, Cheng, Xu, Zhiqiang, Li, Fangyuan, Wei, Ji‐Fu, Ling, Daishun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061383/
https://www.ncbi.nlm.nih.gov/pubmed/33898190
http://dx.doi.org/10.1002/advs.202004115
Descripción
Sumario:Allergic diseases are pathological immune responses with significant morbidity, which are closely associated with allergic mediators as released by allergen‐stimulated mast cells (MCs). Prophylactic stabilization of MCs is regarded as a practical approach to prevent allergic diseases. However, most of the existing small molecular MC stabilizers exhibit a narrow therapeutic time window, failing to provide long‐term prevention of allergic diseases. Herein, ceria nanoparticle (CeNP‐) based phosphatase‐mimetic nano‐stabilizers (PMNSs) with a long‐term therapeutic time window are developed for allergic disease prevention. By virtue of the regenerable catalytic hotspots of oxygen vacancies on the surface of CeNPs, PMNSs exhibit sustainable phosphatase‐mimetic activity to dephosphorylate phosphoproteins in allergen‐stimulated MCs. Consequently, PMNSs constantly modulate intracellular phospho‐signaling cascades of MCs to inhibit the degranulation of allergic mediators, which prevents the initiation of allergic mediator‐associated pathological responses, eventually providing protection against allergic diseases with a long‐term therapeutic time window.